We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$21.6B
AUM Growth
+$3.73B
Cap. Flow
+$2.14B
Cap. Flow %
9.89%
Top 10 Hldgs %
20.71%
Holding
1,837
New
181
Increased
1,318
Reduced
286
Closed
50

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34M
2
XOM icon
ExxonMobil
XOM
+$33.1M
3
JNJ icon
Johnson & Johnson
JNJ
+$32.7M
4
MMM icon
3M
MMM
+$32.4M
5
MCD icon
McDonald's
MCD
+$32.3M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Financials 12.4%
3 Industrials 11.69%
4 Healthcare 11.57%
5 Consumer Staples 11.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIGA icon
1676
SIGA Technologies
SIGA
$223M
$119K ﹤0.01%
25,001
-3,215
-11% -$16.4K
BTU icon
1677
Peabody Energy
BTU
$2.78B
$118K ﹤0.01%
12,923
+46
+0.4% +$529
HLIT icon
1678
Harmonic Inc
HLIT
$1.21B
$117K ﹤0.01%
14,938
+2,625
+21% +$19.6K
GLUU
1679
DELISTED
Glu Mobile Inc.
GLUU
$114K ﹤0.01%
18,868
+5,674
+43% +$32.4K
INO icon
1680
Inovio Pharmaceuticals
INO
$79.8M
$113K ﹤0.01%
2,850
-264
-8% -$7.95K
PBI icon
1681
Pitney Bowes
PBI
$2.42B
$113K ﹤0.01%
28,111
+4,033
+17% +$18.5K
DNR
1682
DELISTED
Denbury Resources, Inc.
DNR
$111K ﹤0.01%
78,862
+13,637
+21% +$15.2K
WPG
1683
DELISTED
Washington Prime Group Inc.
WPG
$111K ﹤0.01%
3,403
+490
+17% +$17.8K
PBYI icon
1684
Puma Biotechnology
PBYI
$406M
$110K ﹤0.01%
12,595
-1,439
-10% -$11.9K
MIK
1685
DELISTED
Michaels Stores, Inc
MIK
$109K ﹤0.01%
13,530
+1,680
+14% +$14.1K
WLL
1686
DELISTED
Whiting Petroleum Corporation
WLL
$109K ﹤0.01%
198
+28
+16% +$13.5K
PRQR icon
1687
ProQR Therapeutics
PRQR
$243M
$106K ﹤0.01%
10,675
+138
+1% +$1.07K
PLUG icon
1688
Plug Power
PLUG
$2.92B
$105K ﹤0.01%
33,201
+6,310
+23% +$19.2K
DHT icon
1689
DHT Holdings
DHT
$2.97B
$103K ﹤0.01%
12,402
+2,305
+23% +$17.1K
TCRT icon
1690
Alaunos Therapeutics
TCRT
$4.74M
$103K ﹤0.01%
145
+23
+19% +$15.8K
WT icon
1691
WisdomTree
WT
$2.97B
$103K ﹤0.01%
21,312
+3,145
+17% +$15.6K
ATRS
1692
DELISTED
Antares Pharma, Inc.
ATRS
$103K ﹤0.01%
21,926
+3,502
+19% +$14.3K
UBX
1693
DELISTED
Unity Biotechnology
UBX
$100K ﹤0.01%
1,382
-92
-6% -$6.49K
GRTS
1694
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$100K ﹤0.01%
+11,121
New +$92.7K
SYRS
1695
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$96K ﹤0.01%
1,388
-156
-10% -$9.46K
KDMN
1696
DELISTED
Kadmon Holdings, Inc.
KDMN
$96K ﹤0.01%
21,217
+6,386
+43% +$23.4K
MBI icon
1697
MBIA
MBI
$288M
$95K ﹤0.01%
+10,200
New +$97K
AMRS
1698
DELISTED
Amyris Inc.
AMRS
$95K ﹤0.01%
30,903
-731
-2% -$2.71K
NOG icon
1699
Northern Oil and Gas
NOG
$2.3B
$94K ﹤0.01%
4,021
+702
+21% +$13.9K
GERN icon
1700
Geron
GERN
$911M
$93K ﹤0.01%
68,317
-2,593
-4% -$3.75K

Similar funds

ProShare Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, ProShare Advisors held 1,837 positions worth $21.6B, up 21% from $17.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

ProShare Advisors deployed $2.14B of net new capital in Q4 2019, opening 181 new positions and adding to 1,318 existing holdings. Its largest new stake was Pennant Group: 484,308 shares worth $16M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was W.R. Berkley, an estimated $12.8M trimmed.

  • ProShare Advisors's largest Q4 2019 buy was Pennant Group: 484,308 shares worth $16M.
  • ProShare Advisors added most to Alphabet (Google) Class A in Q4 2019, an estimated $34M increase.
  • ProShare Advisors's biggest Q4 2019 reduction was W.R. Berkley, cutting an estimated $12.8M.
  • ProShare Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $70M.
  • ProShare Advisors's ten largest holdings make up 21% of its $21.6B portfolio in Q4 2019.
  • ProShare Advisors opened 181 new positions and closed 50 in Q4 2019.
  • ProShare Advisors's portfolio value rose 21% quarter-over-quarter to $21.6B.

Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.